28
Oct
2025

Samsung Biologics Co., Ltd.

Exhibitor at CPHI Frankfurt 2025 stand 5.1B66, Contract Manufacturing and Services
About Us

Samsung Biologics is an end-to-end CDMO partner of choice, providing highly tailored solutions to clients while meeting the evolving needs of the global healthcare industry.

With proven regulatory approvals, we provide seamless offerings from cell-line development to final fill/finish at every stage for biopharmaceutical products.

Our plants are cGMP compliant with a wide range of bioreactor scales. We are committed to maximizing operational efficiency and enhancing our development and manufacturing capabilities to meet growing market demand. Upon...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • KR
  • 2018
    On CPHI since
  • 4
    Certificates
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Primary activities
Contract Manufacturer
View company profile
Contact info
  • Website
  • 300 Songdo Bio Way (daero), Yeonsu-gu, 21987, Incheon, Korea, Republic Of
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 5.1B66, Contract Manufacturing and Services